“…First, it is believed that the composition of gut microbiota and its metabolites and derivatives all play a role in the metabolic homeostasis of the host ( Falcinelli et al, 2015 ), but various endogenous and exogenous factors affect the composition and abundance of the microbiota and it is quite difficult to dissect well the gut microbial-host interactions ( Brugman et al, 2009 ; Roeselers et al, 2011 ; Mottaz et al, 2017 ; Yang et al, 2017 ). Second, although zebrafish are an excellent model organism that has been used to study blood diseases ( Haffter et al, 1996 ; Langenau et al, 2003 ; Dooley et al, 2008 ; van Rooijen et al, 2009 ; Taylor and Zon, 2011 ; Santoriello and Zon, 2012 ), cancer ( Amatruda et al, 2002 ; Ignatius and Langenau, 2009 ; Mione and Trede, 2010 ; Ceol et al, 2011 ; Liu and Leach, 2011 ), heart diseases ( Chen et al, 1996 ; Stainier et al, 1996 ; Poss et al, 2002 ; Poss, 2007 ; Tang et al, 2019 ; Mukherjee et al, 2021 ), muscle disorders ( Bassett and Currie, 2003 ; Follo et al, 2013 ), kidney diseases ( Tobin and Beales, 2008 ; Diep et al, 2011 ; Sander and Davidson, 2014 ; Gehrig et al, 2018 ; Brilli et al, 2019 ), central nervous system diseases ( Stewart et al, 2015 ; Heylen et al, 2021 ), and eye diseases ( Ohnesorge et al, 2019 ; Hong and Luo, 2021 ), zebrafish does have certain disadvantages in mimicking human diseases. These disadvantages include the inclusion of many gene duplications in the zebrafish genome; the phenotypic characteristics of diseases caused by direct homologous genes may differ in zebrafish and humans ( Santoriello and Zon, 2012 ).…”